News from Bala Cynwyd
Stay current with all the latest and breaking news about Bala Cynwyd, compare headlines and perspectives between news sources on stories happening today. In total, 14 stories have been published about Bala Cynwyd which Ground News has aggregated in the past 3 months.
Weather
15°C
Wednesday17° | 29°C
Thursday17° | 23°C
Friday13° | 19°C
Saturday10° | 20°C
Sunday11° | 19°C
Monday10° | 16°C
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Bala Cynwyd News
Latest News Stories
James Beard Awards · Bala CynwydCavatelli with homemade Trapanese pesto is a Sicilian specialty and James Beard Award Finalist and Top Chef Winner Nicholas Elmi brought us into the kitchen where we whipped up this dish in less than five minutes.See the Story
The Dish: Nicholas Elmi's Cavatelli with Trapanese Pesto from The Pump House in Bala Cynwyd
100% Left coverage: 1 sources
Bala Cynwyd · Bala CynwydBALA CYNWYD, Pa., April 15, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Snap One Holdings Corp. (Nasdaq – SNPO) Under the terms of the agreement, Snap One will be acquired by Resi…See the Story
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Snap One Holdings Corp. (Nasdaq – SNPO), Encore Wire Corporation (Nasdaq – WIRE), Progressive Care Inc. (OTCQB - RXMD), HireRight Holdings Corporation (NYSE – HRT)
100% Center coverage: 1 sources
Bala Cynwyd · Bala CynwydBALA CYNWYD, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. AdTheorent Holding Company, Inc. (Nasdaq – ADTH) Under the terms of the agreement, AdTheorent will be acquir…See the Story
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Agiliti, Inc. (NYSE – AGTI), Landos Biopharma, Inc. (Nasdaq – LABP), Fusion Pharmaceuticals Inc. (Nasdaq
100% Center coverage: 1 sources
Bala Cynwyd · Bala CynwydDr. Obioma Martin, a renowned figure in Early Childhood Education, Entrepreneurship, and Leadership, is set to co-author the forthcoming book. The book, slated for a Summer 2024 release, pledges to captivate readers with tales of resilience, tenacity, and indomitable spirit.See the Story
Dr. Obioma Martin Co-Authors Anticipated Inspirational Book, 'Against All Odds' with SuccessBooks and Esteemed Lisa Nichols
Bala Cynwyd · Bala CynwydLarimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the dosing of the first patient in an open label extension (OLE) study for its novel protein replacement therapy, nomlabofusp. Designed to treat Friedreich's ataxia (FA), a rare genetic disease that causes difficulty walking, speech problems, and heart disease.See the Story
Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study
Bala Cynwyd · Bala CynwydBALA CYNWYD, Pa., March 11, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Agiliti, Inc. (NYSE – AGTI) Under the terms of the agreement, Agiliti will be acquired by THL which will acq…See the Story
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), L.S. Starrett Company (NYSE - SCX), Equitrans Midstream Corporation (NYSE - ETRN), Sterling Check Corp. (Nasdaq – STER)
100% Center coverage: 1 sources
Bala Cynwyd · Bala CynwydLarimar Therapeutics, Inc. recently announced that it has successfully closed an underwritten public offering. The company sold 19,736,842 shares of its common stock, including an additional 2,574,370 shares taken up by underwriters exercising their full purchase option. The shares were sold at the public offering price of $8.74 each, matching the closing price of Larimar's common stock on February 13, 2024.See the Story